Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,684,973
+$1,211,002 QoQ
Shares Held
3,906
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,762
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. LLY ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,684,973 | 3,906 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,473,971 | 3,777 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,046,170 | 3,765 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,873,458 | 3,766 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,594,275 | 3,328 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,620,612 | 3,173 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,452,644 | 3,177 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,777,421 | 3,135 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,804,867 | 3,098 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,358,774 | 3,032 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,829,785 | 3,139 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,652,749 | 3,077 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,963,215 | 10,583 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,632,353 | 10,577 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $4,129,236 | 11,287 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $3,645,771 | 11,275 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,260,606 | 3,888 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,120,279 | 3,912 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,051,017 | 3,805 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $874,293 | 3,784 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $860,470 | 3,749 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $724,674 | 3,879 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $648,683 | 3,842 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||